Management of infections of osteoarticular prosthesis

Clinical Microbiology and Infection

Volumn 12, Issue SUPPL. 3, 2006, Pages 93-101

  Barberán, Jose ^a  

^a HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

Author keywords

Arthrodesis; Chronic suppressive therapy; Exchange arthroplasty; Girdlestone; Long term oral antibiotic therapy; One stage prosthetic reimplantation; Prosthesis retention; Prosthetic joint infection; Review; Two stage prosthetic reimplantation

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; FUSIDIC ACID; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; QUINOLONE DERIVATIVE; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTHRODESIS; ARTHROPLASTY; BACTERIUM ISOLATION; CLINICAL TRIAL; DEBRIDEMENT; DISEASE DURATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG CHOICE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOLLOW UP; FOREIGN BODY; HUMAN; JOINT PROSTHESIS; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; MORBIDITY; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSTHESIS INFECTION; PSEUDOMONAS AERUGINOSA; PUS; REVIEW; RISK FACTOR; STANDARDIZATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 33645805031     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01400.x     Document Type: Review

References (101)

1. Masterson EL, Masri BA, Duncan CP. Treatment of infection at the site of total hip replacement. J Bone and Joint Surg 1997; 79A: 1740-1749.
2. Sculco TP. The economic impact of infected joint arthroplasty. Orthopedics 1995; 18: 871-873.
3. Gillespie WJ. Prevention and management of infection after total joint replacement. Clin Infect Dis 1997; 25: 1310-1317.
4. Berbari EF, Hanssen AD, Duffy MC et al. Risk factors for prosthetic joint infection: Case-control study. Clin Infect Dis 1998; 27: 1247-1254.
5. Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. J Bone Joint Surg 1998; 80A: 910-922.
6. Brause BD. Prosthetic joint infections. Curr Opin Rheumatol 1989; 1: 194-198.
7. Petty W, Spanier S, Shuster JJ, Silverthone C. The influence of skeletal implants on incidence of infection. J Bone Joint Surg Am 1985; 67: 1236-1244.
8. Petty W. The effect of methylmethacrylate on bacterial inhibiting properties of normal human serum. Clin Orthop 1978; 132: 266-277.
9. Petty W. The effect of methylmethacrylate on bacterial phagocytosis and killing by human polymorphonuclear leukocytes. J Bone Joint Surg Am 1978; 60: 752-757.
10. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996; 78: 512-523.
11. Saccente M. Periprosthetic joint infections: A review for clinicians. Infect Dis Clin Pract 1998; 7: 431-441.
12. Segawa H, Tsukayama DT, Kyle RF. Becker DA, Gustilo RB. Infection after total knee arthroplasty; a retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am 1999; 81: 1434-1445.
13. Schmalzried TP, Amstutz HC, Au MK, Dorey FJ. Etiology of deep sepsis in total hip arthroplasty: The significance of hematogenous and recurrent infections. Clin Orthop 1992; 280: 200-207.
14. Phelan DM, Osmon DR, Keatnig MR, Hanssen AD. Delayed reimplantation arthroplasty for candidal prosthetic joint infection. A report of 4 cases and review of the literature. Clin Infect Dis 2002; 34: 930-938.
15. Darouiche RO. Device-associated infections: A macroproblem that starts with microadherence. Clin Infect Dis 2001; 33: 1567-1572.
16. Gristina AG, Kolkin J. Total joint replacement and sepsis. J Bone Joint Surg Am 1983; 65: 128-134.
17. Gristina AG. Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science 1987; 237: 1588-1595.
18. Costerton JW, Irvin RT, Cheng K-J. The bacterial glycocalyx in nature and disease. Annu Rev Microbiol 1981; 35: 299-324.
19. Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 2003; 188: 706-718.
20. Anderl JN, Zahller J, Roe F, Stewart PS. Role of nutrient limitation and stationary phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2003; 47: 1251-1256.
21. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990; 162: 96-102.
22. Donlon RM. Biofilm formation: A clinically relevant microbiologic process. Clin Infect Dis 2001; 33: 1387-1392.
23. Barberán J, Bouza E, Aguado JM et al. Diagnóstico tratamiento y prevención de la infección en prótesis articulares. Rev Esp Quimioter 2003; 16: 467-478.
24. Inman RD, Gallegos KJ, Brause BD, Redecha PB, Christian CL. Clinical and microbial features of prosthetic joint infections. Am J Med 1984; 77: 47-53.
25. Choudhry RR, Rice RP, Triffitt PD, Harper WM, Gregg PJ. Plasma viscosity and C-reactive protein after total hip and knee arthroplasty. J Bone Joint Surg Br 1992; 74: 523-524.
26. Spangehl MJ, Younger ASE, Masri BA et al. Diagnosis of infection following total hip arthroplasty. J Bone Joint Surg Am 1997; 79: 1578-1588.
27. Visser M, Bouter LM, McQuillan GM et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
28. Tigges S, Stiles RG, Roberson JR. Appearance of septic hip prostheses on plain radiographs. Am J Roentgenol 1994; 163: 377-380.
29. Goergen TG, Dalinka MK, Alazraki N et al. Evaluation of the patient with painful hip or knee arthroplasty. American College of Radiology. ACR Appropriateness Criteria. Radiol 2000; 215 (Suppl.): 295-298.
30. Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med 1997; 27: 334-345.
31. Love C, Tomas MB, Marwin SE, Pugliese PV, Palestro CJ. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001; 21: 1229-1238.
32. Smith SL, Wastie ML, Forster I. Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin Radiol 2001; 56: 221-224.
33. Love C, Pugliese PV, Afriyie MO, Tomas MB, Marwin SE, Palestro CJ. Utility of F-18 FDG imaging for diagnosing the infected joint replacement. Clin Positron Imaging 2000; 3: 159.
34. Pandey R, Berendt AR, Athanasou NA. Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. Arch Orthop Trauma Surg 2000; 120: 570-574.
35. Atkins BL, Athanasou N, Deeks JJ et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J Clin Microbiol 1998; 36: 2932-2939.
36. Spangehl MJ, Masri BA, O'Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 1999; 81: 672-683.
37. Trampuz A, Steckelberg JM, Osmon DR, Cockerill FR, Hanssen AD, Patel R. Advances in the laboratory diagnosis of prosthetic joint infection. Rev Med Microbiol 2003; 14: 1-14.
38. Mackowiak PA, Jones SR, Smith JW. Diagnostic value of sinus-tract cultures in chronic osteomyelitis. JAMA 1978; 239: 2772-2775.
39. Mariani BD, Martin DS, Levine MJ, Booth RE Jr, Tuan RS. Polymerase chain reaction detection of bacterial infection in total knee arthroplasty. Clin Orthop 1996; 331: 11-22.
40. Athanasou NA, Pandey R, de Steiger R, Crook D, Smith PM. Diagnosis of infection by frozen section during revision arthroplasty. J Bone Joint Surg Br 1995; 77: 28-33.
41. Feldman DS, Lonner JH, Desai P, Zuckerman JD. The role of intraoperative frozen sections in revision total joint arthroplasty. J Bone Joint Surg Am 1995; 77A: 1807-1813.
42. Lentito JR. Prosthetic joint infections. Bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis 2003; 36: 1157-1161.
43. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic joint infections. N Engl J Med 2004; 351: 1645-1654.
44. Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzel J, Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 2004; 53: 127-129.
45. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999; 284: 1318-1322.
46. Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994; 33: 959-967.
47. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections. JAMA 1998; 279: 1537-1541.
48. McGehee RF Jr, Smith CB, Wilcox C, Finland M. Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clindamycin. Am J Med Sci 1968; 256: 279-292.
49. Stein A, Bataille JF, Drancourt M et al. Ambulatory treatment of multidrug-resistant Staphylococcus -infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998; 42: 3086-3091.
50. Turnidge J. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 1999; 58 (Suppl. 2): 29-36.
51. Shuford JA, Steckelberg JM. Role of oral antimicrobial therapy in the management of osteomyelitis. Curr Opin Infect Dis 2003; 16: 515-519.
52. Turnidge J. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 1999; 12 (Suppl. 2): S23-S34.
53. Clemett D, Markham A. Linezolid. Drugs 2000; 59: 815-827.
54. Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg Br 2003; 85: 637-640.
55. Buchholz HW, Elson R, Engelbrecht E. Management of deep infection of total hip replacement. J Bone Joint Surg Br 1981; 63: 342-353.
56. Raut VV, Siney PD, Wroblewski BM. One-stage revision of total hip arthroplasty for deep infection. Clin Orthop 1995; 321: 202-207.
57. Jackson WO, Schmalzried TP. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop 2000; 381: 101-105.
58. Callaghan JJ, Katz RP, Johnston RC. One stage revision surgery of the infected hip: A minimum 10-year follow-up study. Clin Orthop 1999; 369: 139-143.
59. Fitzgerald RH, Jones DR. Hip implant infection. Am J Med 1986; 78 (Suppl. 6B): 225-228.
60. Houshian S, Zawadski AS, Riegels-Neelsen P. Duration of postoperative antibiotic therapy following revision for infected knee and hip arthroplasties. Scand J Infect Dis 2000; 32: 685-688.
61. Insall JN, Thompson FM, Brause BD. Two-stage reimplantation for the salvage of infected total knee arthroplasty. J Bone Joint Surg Am 1983; 65A: 1087-1098.
62. Windsor RE, Insall JN, Urs WK, Miller DV, Brause BD. Two-stage reimplantation for the salvage of total knee arthroplasty complicated by infection. Further follow-up and refinement of indications. J Bone Joint Surg Am 1990; 72A: 272-278.
63. Colyer RA, Capello WN. Surgical treatment of the infected hip implant: two-stage reimplantation with a one-month interval. Clin Orthop 1994; 298: 75-79.
64. Lieberman JR, Callaway GH, Salvati EA, Pellicci PM, Brause BD. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop 1994; 301: 205-212.
65. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001; 32: 419-430.
66. Mont MA, Waldman BJ, Hungerford DS. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study. J Bone and Joint Surg 2000; 82A: 1552-1557.
67. Lonner JH, Siliski JM, Della Valle C, Di Cesare P, Lotke PA. Role of knee aspiration after resection of the infected total knee arthroplasty. Am J Orthop 2001; 30: 305-309.
68. Mont MA, Waldman B, Banerjee C, Pacheco IH, Hungerford DS. Multiple irrigation, debridement, and retention of components in infected total knee arthroplasty. J Arthroplasty 1997; 12: 426-433.
69. Schoifet SD, Morrey BF. Treatment of infection after total knee arthroplasty by debridement with retention of the components. J Bone Joint Surg Am 1990; 72: 1383-1390.
70. Brandt CM, Sistrunk WW, Duffy MC. Staphylococcus aureus prosthetic infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24: 914-919.
71. Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone and Joint Surg 1998; 80A: 1306-1313.
72. Tattevin P, Crémieux AC, Pottier P, Huten D, Carbon C. Prosthetic joint infection: When can prosthesis salvage be consider? Clin Infect Dis 1999; 29: 292-295.
73. Deirmengian C, Greenbaum J, Lotke PA, Booth RE Jr, Lonner JH. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J Arthroplasty Supplement 2003; 1 (18): 22-26.
74. Meehan AM, Osmon DR, Duffy MC, Hanssen AD, Keating MR. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis 2003; 36: 845-849.
75. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990; 162: 96-102.
76. Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994; 33: 959-967.
77. Schwank S, Rajacic Z, Zimmerli W, Blaser J. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother 1998; 42: 895-898.
78. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopaedic implant-related infections with rifampin combinations. Clin Infect Dis 1992; 14: 1251-1253.
79. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampicin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37: 1241-1218.
80. Drancourt M, Stein A, Argenson JN, Roiron R, Groulier P, Raoult D. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacino in combination with rifampicin. J Antimicrob Chemother 1997; 39: 235-240.
81. Zavasky DM, Sande MA. Reconsideration of rifampin. A unique durg for a unique infection. JAMA 1998; 279: 1575-1577.
82. Kadurugamuwa JL, Sin LV, Yu J, Francis KP, Purchio TF, Contag PR. Noninvasive optical imaging method to evaluate postantibiotic effects on biofilm infection in vivo. Antimicrob Agents Chemother 2004; 48: 2283-2287.
83. von Baum H, Bottcher S, Abel R, Gerner HJ, Sonntag HG. Tissue and serum concentrations of levofloxacin in orthopaedic patients. Int J Antimicrob Agents 2001; 18: 335-340.
84. Dellamonica P, Etesse-Carsenti H, Bernard E et al. Pefloxacin in the treatment of bone infections associated with foreign material. J Antimicrob Chemother 1990; 26 (Suppl. B): 198-205.
85. Gomez J, Rodriguez M, Baños V et al. Infección de implantes osteoarticulares: Factores pronósticos e influencia del tratamiento antibiótico prolongado en su evolución. Estudio prospective, 1992-99. Enferm Infecc Microbiol Clin 2003; 21: 232-236.
86. Greenberg RN, Newman MT, Shariaty S, Pectol RW. Ciprofloxacin, lomefloxacin or levofloxacino as treatment for chronic osteomyelitis. Antimicrob Agents Chemother 2000; 44: 164-166.
87. Chien SC, Rogge MC, Gisclon LG, et al. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Antimicrob Agents Chemother 1997; 41: 2256-2260.
88. Barberán J, Carroquino G, Gonzalez F et al. Levofloxacin plus rifampicin treatment of staphylococcal prosthetic-joint infections with prosthesis. Enferm Infecc Microbiol Clin 2004; 22 (Suppl. 1): 122.
89. Drancourt M, Stein A, Argenson JN, Roiron R, Groulier P, Raoult D. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother 1997; 39 (2): 235-240.
90. Bassetti M, Vitale F, Melica G et al. Linezolid in the treatment of Gram-positive prosthetic joint infections. J Antimicrob Agents 2005; 55: 387-390.
91. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. J Bone and Joint Surg 1996; 78A: 512-523.
92. Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopaedic prostheses. Clin Infect Dis 1998; 27: 711-713.
93. Brouqui P, Rousseau MC, Stein A, Drancourt M, Raoult D. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciproloxacin antibiotic combination. Antimicrob Agents Chemother 1995; 39: 2423-2425.
94. Goulet JA, Pellicci PM, Brause BD, Salvati EM. Prolonged suppression of infection in total hip arthroplasty. J Arthroplasty 1988; 3: 109-116.
95. Thornes B, Murray P, Bouchier-Hayes D. Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg Br 2002; 84: 758-760.
96. Rand JA, Bryan RS. The outcome of failed knee arthrodesis following total knee arthroplasty. Clin Orthop 1986; 205: 86-92.
97. Ellingsen DE, Rand JA. Intramedullary arthrodesis of the knee after failed total knee arthroplasty. J Bone Joint Surg Am 1994; 76: 870-877.
98. Damron TA, McBeath AA. Arthrodesis following failed total knee arthroplasty: Comprehensive review and meta-analysis of the recent literature. Orthopedics 1995; 18: 361-368.
99. Kantor GS, Osterkamp JA, Dorr LD, Fischer D, Perry J, Conaty JP. Resection arthroplasty following infected total hip replacement arthroplasty. J Arthroplasty 1986; 1: 83-89.
100. Bourne RB, Hunter GA, Rorabeck CH, Macnab JJ. A six-year follow-up of infected total hip replacements managed by Girdlestone's arthroplasty. J Bone Joint Surg Br 1984; 66: 340-343.
101. McElwaine JP, Colville J. Excision arthroplasty for infected total hip replacements. J Bone Joint Surg Br 1984; 66: 168-171.